Highlights

[PNEPCB] YoY Quarter Result on 2013-03-31 [#2]

Stock [PNEPCB]: PNE PCB BHD
Announcement Date 22-May-2013
Admission Sponsor -
Sponsor -
Financial Year 30-Sep-2013
Quarter 31-Mar-2013  [#2]
Profit Trend QoQ -     -194.23%    YoY -     -455.25%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 22,285 18,243 11,813 13,793 15,958 17,616 14,604 7.29%
  YoY % 22.16% 54.43% -14.36% -13.57% -9.41% 20.62% -
  Horiz. % 152.60% 124.92% 80.89% 94.45% 109.27% 120.62% 100.00%
PBT 114 414 -2,056 -1,839 1,042 166 -1,972 -
  YoY % -72.46% 120.14% -11.80% -276.49% 527.71% 108.42% -
  Horiz. % -5.78% -20.99% 104.26% 93.26% -52.84% -8.42% 100.00%
Tax -7 -4 -3 412 -1,299 0 0 -
  YoY % -75.00% -33.33% -100.73% 131.72% 0.00% 0.00% -
  Horiz. % 0.54% 0.31% 0.23% -31.72% 100.00% - -
NP 107 410 -2,059 -1,427 -257 166 -1,972 -
  YoY % -73.90% 119.91% -44.29% -455.25% -254.82% 108.42% -
  Horiz. % -5.43% -20.79% 104.41% 72.36% 13.03% -8.42% 100.00%
NP to SH 107 410 -2,059 -1,427 -257 -470 -1,972 -
  YoY % -73.90% 119.91% -44.29% -455.25% 45.32% 76.17% -
  Horiz. % -5.43% -20.79% 104.41% 72.36% 13.03% 23.83% 100.00%
Tax Rate 6.14 % 0.97 % - % - % 124.66 % - % - % -
  YoY % 532.99% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 4.93% 0.78% 0.00% 0.00% 100.00% - -
Total Cost 22,178 17,833 13,872 15,220 16,215 17,450 16,576 4.97%
  YoY % 24.36% 28.55% -8.86% -6.14% -7.08% 5.27% -
  Horiz. % 133.80% 107.58% 83.69% 91.82% 97.82% 105.27% 100.00%
Net Worth 49,318 60,488 59,831 53,913 55,895 150,400 52,586 -1.06%
  YoY % -18.47% 1.10% 10.98% -3.55% -62.84% 186.00% -
  Horiz. % 93.79% 115.03% 113.78% 102.52% 106.29% 286.00% 100.00%
Dividend
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Net Worth 49,318 60,488 59,831 53,913 55,895 150,400 52,586 -1.06%
  YoY % -18.47% 1.10% 10.98% -3.55% -62.84% 186.00% -
  Horiz. % 93.79% 115.03% 113.78% 102.52% 106.29% 286.00% 100.00%
NOSH 109,596 65,748 65,748 65,748 65,759 188,000 65,733 8.89%
  YoY % 66.69% 0.00% 0.00% -0.02% -65.02% 186.00% -
  Horiz. % 166.73% 100.02% 100.02% 100.02% 100.04% 286.00% 100.00%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 0.48 % 2.25 % -17.43 % -10.35 % -1.61 % 0.94 % -13.50 % -
  YoY % -78.67% 112.91% -68.41% -542.86% -271.28% 106.96% -
  Horiz. % -3.56% -16.67% 129.11% 76.67% 11.93% -6.96% 100.00%
ROE 0.22 % 0.68 % -3.44 % -2.65 % -0.46 % -0.31 % -3.75 % -
  YoY % -67.65% 119.77% -29.81% -476.09% -48.39% 91.73% -
  Horiz. % -5.87% -18.13% 91.73% 70.67% 12.27% 8.27% 100.00%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 20.33 27.75 17.97 20.98 24.27 9.37 22.22 -1.47%
  YoY % -26.74% 54.42% -14.35% -13.56% 159.02% -57.83% -
  Horiz. % 91.49% 124.89% 80.87% 94.42% 109.23% 42.17% 100.00%
EPS 0.10 0.62 -3.13 -2.80 1.58 0.25 -3.00 -
  YoY % -83.87% 119.81% -11.79% -277.22% 532.00% 108.33% -
  Horiz. % -3.33% -20.67% 104.33% 93.33% -52.67% -8.33% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.4500 0.9200 0.9100 0.8200 0.8500 0.8000 0.8000 -9.14%
  YoY % -51.09% 1.10% 10.98% -3.53% 6.25% 0.00% -
  Horiz. % 56.25% 115.00% 113.75% 102.50% 106.25% 100.00% 100.00%
Adjusted Per Share Value based on latest NOSH - 176,538
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 12.62 10.33 6.69 7.81 9.04 9.98 8.27 7.29%
  YoY % 22.17% 54.41% -14.34% -13.61% -9.42% 20.68% -
  Horiz. % 152.60% 124.91% 80.89% 94.44% 109.31% 120.68% 100.00%
EPS 0.06 0.23 -1.17 -0.81 -0.15 -0.27 -1.12 -
  YoY % -73.91% 119.66% -44.44% -440.00% 44.44% 75.89% -
  Horiz. % -5.36% -20.54% 104.46% 72.32% 13.39% 24.11% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.2794 0.3426 0.3389 0.3054 0.3166 0.8519 0.2979 -1.06%
  YoY % -18.45% 1.09% 10.97% -3.54% -62.84% 185.97% -
  Horiz. % 93.79% 115.01% 113.76% 102.52% 106.28% 285.97% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 -
Price 0.5150 1.0500 0.8000 0.2800 0.3500 0.4000 0.4200 -
P/RPS 2.53 3.78 4.45 1.33 1.44 4.27 1.89 4.98%
  YoY % -33.07% -15.06% 234.59% -7.64% -66.28% 125.93% -
  Horiz. % 133.86% 200.00% 235.45% 70.37% 76.19% 225.93% 100.00%
P/EPS 527.50 168.38 -25.55 -12.90 -89.56 -160.00 -14.00 -
  YoY % 213.28% 759.02% -98.06% 85.60% 44.03% -1,042.86% -
  Horiz. % -3,767.86% -1,202.71% 182.50% 92.14% 639.71% 1,142.86% 100.00%
EY 0.19 0.59 -3.91 -7.75 -1.12 -0.63 -7.14 -
  YoY % -67.80% 115.09% 49.55% -591.96% -77.78% 91.18% -
  Horiz. % -2.66% -8.26% 54.76% 108.54% 15.69% 8.82% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.14 1.14 0.88 0.34 0.41 0.50 0.53 13.60%
  YoY % 0.00% 29.55% 158.82% -17.07% -18.00% -5.66% -
  Horiz. % 215.09% 215.09% 166.04% 64.15% 77.36% 94.34% 100.00%
Price Multiplier on Announcement Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 27/05/16 29/05/15 26/05/14 22/05/13 24/05/12 30/05/11 25/05/10 -
Price 0.4950 1.0300 0.7600 0.3250 0.2800 0.4000 0.2300 -
P/RPS 2.43 3.71 4.23 1.55 1.15 4.27 1.04 15.18%
  YoY % -34.50% -12.29% 172.90% 34.78% -73.07% 310.58% -
  Horiz. % 233.65% 356.73% 406.73% 149.04% 110.58% 410.58% 100.00%
P/EPS 507.01 165.17 -24.27 -14.97 -71.64 -160.00 -7.67 -
  YoY % 206.96% 780.55% -62.12% 79.10% 55.23% -1,986.05% -
  Horiz. % -6,610.30% -2,153.46% 316.43% 195.18% 934.03% 2,086.05% 100.00%
EY 0.20 0.61 -4.12 -6.68 -1.40 -0.63 -13.04 -
  YoY % -67.21% 114.81% 38.32% -377.14% -122.22% 95.17% -
  Horiz. % -1.53% -4.68% 31.60% 51.23% 10.74% 4.83% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.10 1.12 0.84 0.40 0.33 0.50 0.29 24.86%
  YoY % -1.79% 33.33% 110.00% 21.21% -34.00% 72.41% -
  Horiz. % 379.31% 386.21% 289.66% 137.93% 113.79% 172.41% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS